LifeMD, Inc. (NASDAQ:LFMDP) Short Interest Up 77.8% in September

LifeMD, Inc. (NASDAQ:LFMDPGet Free Report) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totaling 1,600 shares, an increase of 77.8% from the August 31st total of 900 shares. Based on an average daily volume of 2,600 shares, the short-interest ratio is presently 0.6 days. Based on an average daily volume of 2,600 shares, the short-interest ratio is presently 0.6 days.

LifeMD Price Performance

NASDAQ LFMDP opened at $23.80 on Friday. The company’s 50 day moving average is $23.88 and its 200-day moving average is $23.97. LifeMD has a 12-month low of $21.14 and a 12-month high of $27.44.

LifeMD Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Friday, October 3rd will be given a dividend of $0.5547 per share. The ex-dividend date is Friday, October 3rd. This represents a $2.22 annualized dividend and a dividend yield of 9.3%.

About LifeMD

(Get Free Report)

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.

Featured Stories

Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.